Accredo® Specialty Pharmacy’s advanced storage and delivery ensures safe delivery of rare therapies

Delivering therapies with care and precision

In the rare therapies landscape, the safe and timely delivery of medications is critical to ensuring positive patient outcomes. Accredo Specialty Pharmacy’s Rare Disease Therapeutic Resource Center^® (TRC) has advanced storage and delivery capabilities, which set a new standard for ensuring therapies reach patients efficiently and securely.

Revolutionizing cold chain technology with IceGen

One of the standout innovations is the proprietary IceGen algorithm, a dynamic solution designed to revolutionize cold chain technology. IceGen goes beyond traditional packing methods, which rely on standardized seasonal temperature configurations generic summer or winter configurations, by factoring in precise variables to safeguard the therapy’s stability from the moment it leaves our facility until it arrives in the patient’s hands.

Here’s how the IceGen algorithm works:

1. Gather: IceGen begins by analyzing multiple variables, including temperature requirements, origin and destination temperature forecasts and transit duration. Before the order is packed, current weather data is incorporated to create a temperature profile for the entire journey.
2. Predict: Based on this data, IceGen calculates the exact number and configuration of ice or gel packs needed to maintain the required temperature throughout transit. The algorithm also accounts for the unpredictability of real-world conditions to ensure stability.
3. Determine: IceGen determines the most efficient packaging configuration by analyzing all shipping factors, including the type of therapy being shipped. This precision minimizes waste while ensuring the safe arrival of the medication.
4. Choose: Finally, the algorithm selects the optimal packaging solution, providing detailed instructions to the Accredo team on how to prepare the shipment for its journey to the patient.

This level of precision not only guarantees patient safety but also reflects Accredo’s commitment to exceeding industry standards in medication handling:

• 99% dispensing accuracy rate with IceGen.1
• 98% standard guaranteed “promise to deliver” rate for clients.

CuraScript SD^®: Expansive specialty distribution capabilities

Through our work with CuraScript SD, rare disease therapy manufacturers gain access to added delivery models, such as buy-and-bill or direct-to-consumer options, along with robust supply chain management resources.

CuraScript SD helps bring a range of delivery programs and offerings, from specialized teams to a robust distribution process, all to help ensure prompt delivery for rare therapies. This collaboration provides seamless access to essential therapies, complementing Accredo’s expertise with customized business solutions for manufacturers and health care providers.

Innovation in rare disease care

Accredo’s capabilities reflect its broader commitment to clinical excellence and patient-centered care. By continuously innovating and refining its processes, Accredo ensures that rare therapies are delivered safely, accurately and efficiently to the patients who need them most. Whether through its proprietary IceGen algorithm, meticulous packaging protocols or tailored delivery solutions, Accredo is leading the way in safeguarding the future of rare disease care.

Learn more about how our capabilities support the safe delivery of rare therapies by downloading our white paper on the capabilities and benefits of partnering with the right specialty pharmacy.

• 1

  Accredo BoB data 2024